Use access key #2 to skip to page content.
$21.98 0.10 (0.46%)
8/29/2008 4:00 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating:
**

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

View All Commentary (AMLN)

Recs

0

Avatar MudgieBoy (77.50) Submitted: 8/26/06 2:29 AM : Underperform Start Price: $45.15 AMLN Score: 50.64

Burning cash like it is weeds.

Report this Post Replies: 0 | Reply

Featured Broker Partners